Answers are grounded in this paper and cite their sources.
This study examines the normative gap between the cosmetic notification mechanism, which places initial responsibility on business operators, and the civil liability regime, particularly in cases involving discrepancies in the formulation of mercury-containing cosmetics discovered after the products have obtained notification numbers and entered the market. This study employs normative legal research using statutory, conceptual, and comparative legal approaches to examine the legal framework for consumer protection in Indonesia and functionally compare it with the cosmetic supervision and liability system in South Korea. The novelty of this research lies in positioning post-notification formulation discrepancies in mercury-containing cosmetics as the central issue of legal liability, examining the integration of consumer protection law, technical supervision, and health-related criminal law, and using actual judicial cases as the basis for normative evaluation. The findings indicate that the primary problem does not stem solely from a legal vacuum, but also from the lack of clarity regarding business operators’ obligations to continuously ensure the conformity, safety, and quality of cosmetic formulations after products enter the market. Furthermore, the interaction among the relevant legal regimes remains insufficiently integrated, potentially creating legal uncertainty in determining the applicable grounds and subjects of liability. The comparison with South Korea highlights the importance of clearly identifying the responsible party, requiring the reporting of changes in product composition, and strengthening product traceability to improve the effectiveness of post-market surveillance. Accordingly, strengthening consumer protection for cosmetic products in Indonesia requires the harmonization of legal norms, clarification of business operators’ obligations throughout the product distribution cycle, and integration of supervisory and liability mechanisms to ensure legal certainty and consumer safety.
No takes yet. Share an insight, caveat, or question.
Armayanti et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: